Lori taylor
Company: Annexon Biosciences
Job title: SVP
Seminars:
Panel Discussion: Upstream, Downstream or Proximal – Where, When, & How to Target? 11:45 am
Discussing acute versus chronic inflammatory disorders and which proteins within the cascade we can target Understanding disease progression and debating systemic or tissue specific targeting Can combination therapies bridge the gaps and ensure efficacy for treatment?Read more
day: Conference Day One
GBS vs. GA: Treating Both Acute & Chronic Diseases with C1q Inhibition 1:30 pm
Discussing the efficacy of ANX005 in treating Guillain-Barre Syndrome Optimizing dosage for acute and chronic indications Summarizing the differences in the challenges of complement inhibition in acute and chronic indicationsRead more
day: Conference Day One